Table 1 Lipid, demographic, genetic and MetS-related characteristics for participants by group
From: Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS
| Â | Group 1 | Group 2 |
|---|---|---|
N | 200 | 51 |
Gender; % male | 72 | 61 |
Age, y | 50.51 (14.99) | 50.94 (14.84) |
Lipoprotein diameters | ||
VLDL** | 53.07 (3.33) | 65.74 (4.92) |
LDL | 19.79 (0.43) | 20.05 (0.56) |
HDL | 8.39 (0.23) | 8.45 (0.24) |
Sera lipoprotein particle concentrations (nmol/L) | ||
VLDL | 108.62 (51.43) | 76.43 (54.20) |
LDL | 1760.02 (469.19) | 1624.28 (488.76) |
HDL | 29.06 (5.49) | 30.22 (5.27) |
MetS, and related features | ||
Waist circumference; cm | 106.54 (14.80) | 109.27 (14.26) |
Fasting glucose, (mmol/L)** | 5.99 (1.19) | 6.37 (1.70) |
Diabetes, %** | 13 | 24 |
Fasting TGs (mmol/L)** | 2.37 (1.07) | 3.43 (3.76) |
HOMA-IR* | 4.92 (3.08) | 6.56 (4.78) |
Total No of MetS counts | 3.44 (1.19) | 3.45 (1.15) |
Individuals meeting ATP-III MetS criteria; % | 72.5 | 76.5 |
Genotype data, Minor allele carriers, % | ||
LPL S447X* | 14 | 25 |
D9N | 7 | 4 |